Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists
Products/Services Used |
Details |
Operation |
|
All binding assays were performed in 96-well plates (UniFilter 96 GF/C, PerkinElmer) with membrane preparation expressing human M3 receptors (transfected CHO-K1 cells, GenScript USA Inc.). |
|
ammonium salts · antagonists · nitrogen heterocycles · stability · structure–activity relationships